SIGA TECHNOLOGIES INC. - COMMON STOCK

SIGA Reports Financial Results for Three Months Ended March 31, 2025

08 May 2025 13:05:01 By Nasdaq GlobeNewswire

SIGA to Host Business Update Call on May 8, 2025 Following Release of First-Quarter 2025 Results

01 May 2025 04:30:00 By Nasdaq GlobeNewswire

SIGA Declares Special Cash Dividend of $0.60 Per Share

08 Apr 2025 04:30:00 By Nasdaq GlobeNewswire

SIGA Appoints Retired General John M. Keane to its Board of Directors

18 Mar 2025 04:30:00 By Nasdaq GlobeNewswire

SIGA Reports Financial Results for Three and Twelve Months Ended December 31, 2024

11 Mar 2025 13:05:00 By Nasdaq GlobeNewswire

SIGA to Host Business Update Call on March 11, 2025 Following Release of Fourth-Quarter and Full Year 2024 Financial Results

04 Mar 2025 04:30:00 By Nasdaq GlobeNewswire

TEPOXX (tecovirimat) Approved in Japan for the Treatment of Orthopoxviruses

02 Jan 2025 04:30:00 By Nasdaq GlobeNewswire

Interim Results from STOMP Study of SIGA’s Tecovirimat in Treatment of Mpox Announced

10 Dec 2024 13:00:43 By Nasdaq GlobeNewswire

SIGA Reports Financial Results for Three and Nine Months Ended September 30, 2024

07 Nov 2024 13:05:02 By Nasdaq GlobeNewswire

SIGA to Host Business Update Call on November 7 Following Release of Third-Quarter 2024 Financial Results

31 Oct 2024 04:30:00 By Nasdaq GlobeNewswire

SIGA Enters into Exclusive License Agreement with Vanderbilt University for Novel Poxvirus Monoclonal Antibodies

22 Oct 2024 04:30:00 By Nasdaq GlobeNewswire

SIGA Announces Agreement to Supply TPOXX® in Morocco

08 Oct 2024 04:30:00 By Nasdaq GlobeNewswire

SIGA Announces New Contract Awarded by U.S. Department of Defense for the Procurement of $9 Million of TPOXX®

21 Aug 2024 13:00:00 By Nasdaq GlobeNewswire

Topline Results from PALM 007 Study of SIGA’s Tecovirimat in Treatment of Mpox Released

15 Aug 2024 04:35:00 By Nasdaq GlobeNewswire

SIGA Reports Financial Results for Three and Six Months Ended June 30, 2024

01 Aug 2024 13:05:00 By Nasdaq GlobeNewswire

SIGA to Host Business Update Call on August 1 Following Release of Second-Quarter 2024 Financial Results

25 Jul 2024 04:30:00 By Nasdaq GlobeNewswire

SIGA Announces U.S. Government Procurement Order of $113 Million for Oral TPOXX®

19 Jul 2024 05:00:00 By Nasdaq GlobeNewswire

SIGA Announces Agreement to Sell TPOXX® to ASEAN Member States

17 Jun 2024 13:05:00 By Nasdaq GlobeNewswire

SIGA Reports Financial Results for Three Months Ended March 31, 2024

07 May 2024 13:05:00 By Nasdaq GlobeNewswire

SIGA Technologies to Host Business Update Call on May 7 Following Release of First-Quarter 2024 Financial Results

01 May 2024 14:00:00 By Nasdaq GlobeNewswire